C-reactive protein (CRP) as a prognostic biomarker in patients with bladder cancer: A meta-analysis. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not ...
Bladder cancer caught early is often amenable to treatment, but of course late-stage and aggressive characteristics alter the prognosis for the worse. Understanding high-risk features, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback